ISIS optronics GMVH
Executive Summary
A device currently in development at ISIS optronics GMBH in Mannheim, Germany, could give dermatologists and cosmetic surgeons a new way to look at skin, and so help them tailor treatment to individual patients. The device might eventually prove useful for pre-screening pateints for skin diseases such as melanoma, a condition seen with increasing frequency around the glove.
You may also be interested in...
England’s Innovative Medicines Fund To Put Spotlight On Rare Disease Treatments
While the much-anticipated Innovative Medicines Fund is likely to benefit rare diseases in particular, other products must gain too.
Who’s Hired? Formycon Is Latest To Swap CEO
Formycon has become the latest firm to announce a new CEO, after similar moves at Orion and Strides. Meanwhile, Gedeon Richter has made management changes and a new director has joined Coherus.
People On The Move: Appointments At Alliance Pharma, Venture Life, Maxwellia
A round-up of the latest European consumer health industry appointments: Alliance Pharma names Jo LeCouilliard as chair; Venture Life hires Paul McGreevy as non-executive chair; and Maxwellia appoints Ian Adamson as a strategic advisor.